The Molecular Imaging and Contrast Agent Database (MICAD) has uploaded 11 agents.

The PET agents are:

• [11C]DPA-713  and [18F]PBR06, which both targets peripheral benzodiazepine receptor (PBR), also known as translocator protein (TSPO)
• [18F]AV-45, which targets ß-amyloid peptide
• [18F]FB-RMSH, which targets melanocortin-1 (MC-1) receptor (MC1R)

The SPECT agents are:

• 123I-Nicotinamide, which targets gastrin/cholecystokinin-2 receptor (CCK-2R)
• 99mTc-HYNIC-cyclo-MG1, which targets gastrin/cholecystokinin-2 receptor (CCK-2R)

The MRI agents are:

• Gd-DOTA-R832, which targets vascular cell adhesion molecule-1 (VCAM-1)
• Gd-DTPA-g-R826, which targets phosphatidylserine
• USPIO-PHO, which targets ß-amyloid peptide
• VCAM-1-PFC-19mF which targets vascular cell adhesion molecule-1 (VCAM-1)

The optical agent is:

• Avas12a1-IRDye800, which targets vascular endothelial growth factor receptor-2 (VEGFR-2)

The MICAD database currently lists 805 agents and is developed by the National Center for Biotechnology Information at the National Institutes of Health.